Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2010 | 1 |
2011 | 1 |
2012 | 1 |
2014 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer.
Expert Opin Biol Ther. 2011 Dec;11(12):1663-8. doi: 10.1517/14712598.2011.627850. Epub 2011 Oct 13.
Expert Opin Biol Ther. 2011.
PMID: 21995322
Review.
Novel investigational biologics for the treatment of cancer cachexia.
Ma JD, Heavey SF, Revta C, Roeland EJ.
Ma JD, et al.
Expert Opin Biol Ther. 2014 Aug;14(8):1113-20. doi: 10.1517/14712598.2014.907788. Epub 2014 Apr 7.
Expert Opin Biol Ther. 2014.
PMID: 24707881
Review.
Item in Clipboard
A phase II, double-blind, randomised, placebo-controlled study of BMS945429 (ALD518) in patients with rheumatoid arthritis with an inadequate response to methotrexate.
Mease P, Strand V, Shalamberidze L, Dimic A, Raskina T, Xu LA, Liu Y, Smith J.
Mease P, et al.
Ann Rheum Dis. 2012 Jul;71(7):1183-9. doi: 10.1136/annrheumdis-2011-200704. Epub 2012 Feb 10.
Ann Rheum Dis. 2012.
PMID: 22328739
Clinical Trial.
Item in Clipboard
Deal watch : BMS acquires rights for IL-6 inhibitor.
[No authors listed]
[No authors listed]
Nat Rev Drug Discov. 2010 Jan;9(1):10. doi: 10.1038/nrd3094.
Nat Rev Drug Discov. 2010.
PMID: 20043020
No abstract available.
Item in Clipboard
Cite
Cite